34 Maple Street
About Waters Corporation
Waters Corporation is a technology company delivering scientific insights to improve human health and well-being. In partnership with our customers, we ensure the efficacy of the medicines you take, the safety of the food you eat and the water you drink, and the quality of the everyday products you use. Together, we unlock the potential of science to leave this world better than we found it.
341 articles with Waters Corporation
In a season that has seen painful layoffs for many biopharma companies, BioSpace had more registrations in July than in any other month this year. This is indicative of a competitive job market.
Sales of $714 million grew 5% as reported and 10% in constant currency Continued strong momentum as instrument sales grew 12% in constant currency, with double-digit growth across LC, MS and TA product lines Broad-based performance across all end-markets and major geographies, led by mid-teens growth in the U.S.
Waters Collaborates with Leading Researchers and Industry Partners to Advance the Science of Alternative Proteins
Waters Corporation announced it is providing both technology and expertise to help advance plant-based protein science in collaboration with researchers of the Plant Protein Innovation Center at the University of Minnesota.
Waters Corporation (NYSE:WAT) will hold its Q2 2022 financial results conference call live on Tuesday, August 2nd 2022 at 8:00 a.m. eastern time.
Waters Introduces High Resolution Mass Spectrometry Products and Software to Accelerate Drug Development
ASMS 2022 – Waters Corporation unveiled new instruments, software and product enhancements to drive drug discovery and development at the American Society for Mass Spectrometry 2022 Annual Conference.
Waters Corporation Udit Batra Ph.D., President and Chief Executive Officer, will participate in a fireside chat at the Jefferies 2022 Global Healthcare Conference in New York City on Wednesday, June 8th, 2022 at 4:30PM Eastern Standard Time.
Waters Corporation and The University of Delaware announced the grand opening of Immerse™ Delaware, a new Waters innovation and research laboratory.
Waters Corporation (NYSE: WAT) today announced its financial results for the first quarter of 2022.
Waters Corporation (NYSE:WAT) announced today that it will host its 2022 Investor Day on Thursday, May 19, 2022, starting at 8:45 a.m. (ET) at the New York Stock Exchange, 11 Wall St, New York, NY 10005.
Waters Introduces Xevo TQ Absolute – The Most Sensitive and Compact Benchtop Tandem Quadrupole Mass Spectrometer
Waters Corporation introduced the new Xevo™ TQ Absolute system, the most sensitive and compact benchtop tandem mass spec in its class.i This press release features multimedia.
Waters Introduces Faster, Reliable and Automated Solution for Mass and Purity Analysis of Biomolecules
Waters Corporation introduced new software and analytical columns to aid biomolecule drug discovery and development.
Waters Corporation (NYSE:WAT) Udit Batra Ph.D., President and Chief Executive Officer, will participate in a fireside chat at the Cowen Healthcare Conference on Wednesday, March 9th, 2022 at 2:10PM Eastern Standard Time.
Waters Corporation (NYSE: WAT) today announced fourth quarter 2021 sales of $836 million, an increase of 6% as reported and 8% in constant currency, compared to sales of $787 million for the fourth quarter of 2020.
Waters Acquires Charge Detection Mass Spectrometry Technology to Broaden its Application in Cell and Gene Therapy
Waters has acquired technology assets and intellectual property rights of Megadalton Solutions, an early-stage developer of charge detection mass spectrometry (CDMS).
U.S. Food and Drug Administration Expands Deployment of Waters Corporation Software to Support its Medical Products Testing Labs
Waters Corporation announced the U.S. Food and Drug Administration’s Office of Regulatory Affairs has purchased Waters™ Empower™ Chromatography Data Software and NuGenesis™ Laboratory Management Software, expanding its deployment of Waters’ software to support its medical products testing operations across its five field science laboratories.
Waters Corporation will webcast its Q4 2021 financial results conference call live on Tuesday, February 1st 2022 at 8:00 a.m. eastern time.
Waters Accelerates Quantitative Mass Spectrometry With New Application on waters_connect Informatics Platform
Waters Corporation announced it is expanding its waters_connect™ informatics software platform to support customers analyzing food and environmental samples with Waters’ tandem quadrupole mass spectrometers.
Waters Corporation Presentation at the 40th Annual J.P. Morgan Healthcare Conference to be Webcast Live
Waters Corporation (NYSE:WAT) Udit Batra Ph.D., President and Chief Executive Officer, will speak to the investment community at the J.P. Morgan Healthcare Conference virtually on Monday, January 10th, 2022 at 8:15AM Eastern Standard Time.
Waters Corporation Presentation at the Evercore ISI HealthCONx 2021 Virtual Health Care Conference to Be Webcast Live
Waters Corporation (NYSE:WAT) Udit Batra Ph.D., President and Chief Executive Officer, will speak to the investment community at the Evercore ISI 4th Annual HealthCONx Healthcare Conference virtually on Tuesday, November 30th, 2021 at 12:10PM Eastern Standard Time.
Waters Corporation (NYSE: WAT) today announced third quarter 2021 sales of $659 million, an 11% increase as reported, compared to sales of $594 million for the third quarter of 2020.